Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38457349.
- Also identified by DOI 10.1093/infdis/jiae023 and PMC identifier 11420768.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assessed the epidemiology of hepatitis delta virus (HDV) within the University of Utah UHealth health care system (2000-2021). Analysis of HDV/HBV testing, diagnostic codes, liver enzymes, and comorbidities was performed. Among the 1962 HBV patients, only 22.2% underwent HDV testing, revealing an 8.3% positivity rate for HDV coinfections. This study observed a consistent increase in HBV and HDV cases, with higher HDV detection rates linked to increased testing. Limited HDV testing and potential screening biases were evident. Improved HDV testing and surveillance are crucial for early detection and implementation of targeted therapies.
Medical subject headings
- Hepatitis Delta Virus
- Hepatitis D
- Hepatitis B
- Mass Screening